Evaluación sintomática del paciente oncológico en urgencias

Emergencias: Revista de la Sociedad Española de Medicina de Urgencias y Emergencias, ISSN 1137-6821, Vol. 21, Nº. 3, 2009, pags. 186-188 01/2009; 21.
Source: OAI


Objetivos: Describir el perfil del paciente oncológico atendido en el servicio de urgencias de un hospital terciario, los motivos de consulta y su manejo clínico. Método: Desde octubre de 2007 a marzo de 2008, se recogieron las características de estos pacientes junto con los motivos de consulta y el manejo clínico de los pacientes oncológicos en el servicio de urgencias. Resultados: Se atendieron un total de 251 pacientes (12 pacientes/semana): 65 pacientes padecían cáncer de pulmón (25,9%), 47 padecían cáncer colorrectal (18,7%), y 32 cáncer de mama (12,7%). De todos ellos, 185 tenían enfermedad metastásica (73,7%) y 133 recibían tratamiento quimioterápico (52,9%). Los motivos de consulta más frecuentes fueron fiebre en 46 casos (18,3%), dolor relacionado con el tumor en 39 casos (15,5%), disnea en 36 casos (14,3%) y náuseas-vómitos en 28 casos (11,2%). Tras la atención urgente, 121 pacientes precisaron ingreso hospitalario (48,2%). Conclusiones: Los pacientes metastáticos y aquellos que están en tratamiento activo son los pacientes oncológicos que más demandan atención urgente y casi la mitad precisan ingreso hospitalario.

Download full-text


Available from: Ana Isabel Ferrer Pérez

  • No preview · Article · Jul 2011 · Revista Clínica Española
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: To measure the frequency, trends and distribution of cancers with suspected diagnosis in the Hospital Emergency Services (HES) in Asturias during 2006-12. To describe the clinical characteristics of these cancers and to determine if they differ from those whose diagnosis is made in other services. Methods: Population based descriptive study of cancers registered in the Hospital Tumour Registry of Asturias (Spain), which provided data of patient characteristics, cancer variables (site, histology, stage, metastasis and delay), the hospital and service of diagnosis. Patients with confirmed diagnosis of cancer (non-melanoma of skin excluded) in the study period were included (N=26,020). Differences of cancer cases according to the service that had performed the suspected diagnosis were analyzed. We performed regression analysis of the time between the first symptom and the suspected diagnosis, the definitive diagnosis and treatment, controlling main confounders. Results: Seven point nine percent (n=2,056) of all cancer cases were suspected in a HES (annual minimum of 5.3% and maximum 10.4%, with an upward trend). These patients were mainly men (60.6%), with a mean age of 67.7 years, and with lung (21.0%) and colon cancer (15.5%). The HES ranks 6th place in the list of services which diagnosed cancer. There was more diagnosis of advanced tumours (33.0%) and metastasis (29.5%) in the HES. The HES halved the time between the first symptom and the SD (-63.3 days; p<0.001), and between definitive diagnosis and initiation of treatment (-15.9 days; p<0.001) compared to the other services. Conclusions: The HES contribute significantly to suspected cancer diagnosis, mainly advanced and metastatic tumours in the respiratory and digestive system, whose symptoms escape accidental diagnosis conducted in primary care, and they start abruptly.
    No preview · Article · May 2014 · Anales del sistema sanitario de Navarra
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: to assess the causes of the Emergency Department visits in cancer patients treated with antineoplastics. The secondary objective is to analyse the use of growth stimulating factors in febrile neutropenia. Methods: a retrospective observational study was conducted during six months of 2012. The adult patients diagnosed with solid tumour that visited the Emergency Department and whose physician was an oncologist, were included. Results: a total of 83 patients fulfilled the inclusion criteria. The causes of visits were: 63% due to the tumour, 31% due to the chemotherapy toxicity and 6% due to other causes. In patients with chemotherapy toxicity, 65% had fever or infection, 50% pain and 42% febrile neutropenia. The treatment and prophylaxis with filgrastim followed the recommendations. Conclusions: in cancer patients, most of emergencies are due to the tumour. The management of the pain, the fever and the neutropenia is important.
    No preview · Article · Nov 2015 · Revista de la Sociedad Espanola de Farmacia Hospitalaria